Cancer
SART3 309-317 (HLA-A*02:01) RLAEYQAYI
Product number: EP11417_1
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
3 weeks
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
The peptide SART3 309-317 (HLA-A*02:01) with the amino acid sequence RLAEYQAYI is a linear peptidic epitope (epitope ID 1715264) studied as part of Spliceosome associated factor 3, U4/U6 recycling protein (UniProt:Q15020) from Homo sapiens (human).
SART3 309-317 (HLA-A*02:01) has been studied for immune reactivity in publications and has been tested in T cell assays and B cell assays.
TechData
| Sequence: | RLAEYQAYI |
| Gene: | SART3 |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Squamous cell carcinoma antigen recognized by T-cells 3 |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Application: | Flow Cytometry, Immunohistochemistry |
| Indication: | Cancer |
| Purity: | 95% HPLC-MS |